AAA
Affinity Asset Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.4M | Sell |
1,100,000
-228,175
| -17% | -$7.14M | 4.7% | 3 |
|
|
2025
Q1 | $44.6M | Buy |
1,328,175
+166,938
| +14% | +$5.6M | 4.25% | 1 |
|
|
2024
Q4 | $45.5M | Buy |
1,161,237
+17,216
| +2% | +$675K | 6.1% | 1 |
|
|
2024
Q3 | $45M | Buy |
1,144,021
+149,794
| +15% | +$5.9M | 6.15% | 1 |
|
|
2024
Q2 | $38.8M | Buy |
994,227
+156,840
| +19% | +$6.12M | 4.47% | 1 |
|
|
2024
Q1 | $36M | Buy |
837,387
+377,387
| +82% | +$16.2M | 4.46% | 2 |
|
|
2023
Q4 | $21.2M | Buy |
460,000
+159,562
| +53% | +$7.35M | 3.87% | 5 |
|
|
2023
Q3 | $10.3M | Buy |
300,438
+240,062
| +398% | +$8.2M | 2.89% | 11 |
|
|
2023
Q2 | $2.32M | Sell |
60,376
-29,624
| -33% | -$1.14M | 0.81% | 30 |
|
|
2023
Q1 | $3.22M | Buy |
90,000
+40,000
| +80% | +$1.43M | 1.06% | 25 |
|
|
2022
Q4 | $1.97M | Buy |
+50,000
| New | +$1.97M | 0.77% | 32 |
|
|
2022
Q2 | – | Sell |
-80,000
| Closed | -$2.45M | – | 63 |
|
|
2022
Q1 | $2.45M | Sell |
80,000
-70,500
| -47% | -$2.16M | 0.39% | 30 |
|
|
2021
Q4 | $4.7M | Buy |
150,500
+100,500
| +201% | +$3.14M | 1.71% | 22 |
|
|
2021
Q3 | $764K | Buy |
+50,000
| New | +$764K | 0.19% | 58 |
|